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Abstract
Radioactive waste from nuclear installations and nuclear reprocessing plants, 
nuclear accidents, and radioactive fallout from nuclear weapons testing constitute a 
serious problem facing future generations. Marine algae and phytoplanktons accumu-
late radionuclides from their surroundings and are used as bioindicators of radioac-
tive pollution in the environment. In Northern Europe, the affected marine systems 
include the Irish Sea, the Baltic Sea, and the North Sea. The main sources of this 
radioactive contamination are global fallout from nuclear weapons tests, river trans-
port from Siberia, and marine transport of discharges from Sellafield and Chernobyl. 
An increased leukemia incidence has been observed in young children at Seascale near 
Sellafield, and an elevated incidence of leukemia has been recorded among young 
people (0–24 years) in the French canton of Beaumont-Hague close to the Cap de la 
Hague nuclear reprocessing facility. In Scandinavia, scientists suspect that people in 
parts of Sweden are still dying from cancer caused by radiation from the Chernobyl 
accident. Moreover, the Baltic Sea is contaminated with man-made plutonium radio-
nuclides from nuclear reprocessing. However, some experts are able to dismiss the 
above relationships due to important uncertainties over the estimation of radiation 
doses from environmental discharges based on a mutational theory of carcinogenesis. 
Consequently, it appears to be of paramount importance to reevaluate the current 
methods for cancer risk assessment in the case of radiation exposure within the 
context of an apoptotic model of carcinogenesis that could explain such a discrepancy. 
According to this new model, subtle differences in gene expression in response to a 
carcinogen can initiate cell death or apoptosis and act as a trigger for carcinogenesis. 
Simultaneously, future implications for human gene evolution are unavoidable.
Keywords: nuclear reprocessing, plutonium, leukemia, lung cancer, alpha- and 
gamma-radiation carcinogenesis
1. Introduction
Sellafield (UK) and Cap de la Hague (France) are the two largest centers for 
commercial reprocessing of nuclear fuel in the world. This process involves the 
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dissolution of spent fuel in boiling concentrated nitric acid, which results in the 
subsequent physicochemical separations of uranium and plutonium. Reprocessing 
operations release considerable volumes of liquid and gaseous wastes into the 
environment. These include large volumes of radioactivity, typically on a scale of 
several thousand more than that released by nuclear reactors.
1.1 Sellafield
In the case of Sellafield, aerial emissions have deposited two to three times the 
plutonium fallout from total atmospheric nuclear weapons testing within a 20-km 
radius of this facility. Since the inception of reprocessing at Sellafield in the 1960s, 
it has been estimated that between 250 and 500 kg of plutonium from the plant is 
now adsorbed onto sediments on the bed of the Irish Sea. Migration of these under-
sea deposits to coastal environments potentially represents a long-term hazard of 
unknown proportions [1].
The village of Seascale lies roughly south of Sellafield. A stretch of deserted beach 
runs northward toward the Sellafield plant, which has its discharge pipeline just 2 km 
off the coast. The beach used to be popular with bathers, but, now, many guide books 
make reference to the radioactive pollution from Sellafield. In fact, in 1993, a govern-
ment survey found that the incidence of leukemia and non-Hodgkin’s lymphoma 
was 14 times the national average and twice that in other areas of West Cumbria [2]. 
An increased incidence of retinoblastoma in children and a statistically significant 
increase in stillbirth risk in the Sellafield region have also been observed [1].
The main pathways for radiation exposure for people living in the vicinity 
of Sellafield are external radiation from airborne and deposited radionuclides, 
internal exposure resulting from inhalation of airborne radionuclides, and inges-
tion of radionuclides from contaminated food. In Sellafield, locally caught fish and 
shellfish have been found to be contaminated with toxic radionuclides, particularly, 
plutonium and americium [1].
1.2 Cap de la Hague
An elevated incidence of leukemia has been recorded among young people 
(0–24 years) in the French canton of Beaumont-Hague close to the Cap de la Hague 
nuclear reprocessing facility. In the latter case, two factors were found to be corre-
lated strongly with increased leukemia risk: the use of local beaches for recreational 
activities by children and mothers during gestation and fish and shellfish consump-
tion. In addition, a 3-year French epidemiological study in the region found a 
higher than expected morbidity in men from leukemia and respiratory cancers and 
leukemia and lung cancer in women [1].
1.3 Sea-to-land transfer
In Denmark, women have the highest rates of all forms of cancer in the Nordic 
countries [3], while their fish-eating neighbors in Norway have the highest 
rates of colorectal cancer for women in the world [4]. It is of some interest that 
Denmark, Ireland, and Norway have protested for many years over reprocessing 
at Sellafield and La Hague due to concern about the local impact on environment 
and health [1].
In parts of Sweden, scientists suspect that people are still dying from cancer 
caused by radiation from the Chernobyl accident [5]. Radioactive polonium, 
uranium, and plutonium have also been detected in the Baltic Sea where they are 
accumulated by various marine organisms. While the polonium and uranium 
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isotopes may be derived from natural geological sources, the principle sources of 
plutonium in the Baltic Sea are radioactive fallout from nuclear weapons testing, 
releases from nuclear power plants and nuclear processing facilities at Sellafield and 
Cap de la Hague, and radioactive debris originating from Chernobyl [6].
It has now been established that a potentially important pathway for radioactive 
discharges to humans involves sea-to-land transfer since significant quantities of 
radionuclides can become airborne in seaspray and be transported inland by the 
wind [7]. Thus, concerns over nuclear reprocessing have led to a number of stud-
ies examining the health risks that may be associated with such nuclide discharges 
and, ultimately, have resulted in a scientific report commissioned by the European 
Parliament [1].
1.4 Scientific and technological options assessment
The findings of this report suggest that the Sellafield facility (closed in 2018) 
was found to be in violation of several key European requirements. Marine 
discharges at Sellafield led to significant radionuclide concentrations in certain 
foodstuffs exceeding EC limits (and, in this case, the Irish fishwives’ tales about 
mutant fish were very likely true) [8]. Radionuclide discharges to the Sellafield 
marine environment resulted in doses to critical groups exceeding ten times the 
current UK and three times the EU limits. Increases of key radionuclide releases 
from in the late 1990s and projected future releases from Sellafield were not in 
keeping with European standards or their UK obligations as a member state of 
the European Union (EU). Generally, radionuclide concentrations in the Cap 
de la Hague environment have decreased since the 1980s, and calculated doses 
from routine releases remain well within EU limits. However, past accidents at 
La Hague have led to population doses significantly exceeding EU limits and are 
estimated to be responsible for 36% of the leukemia risk level for the 0–24-year 
age category around the site.
Contaminated marine environments can result in radiation exposure and 
radionuclide accumulation by marine life from plants to fish, and transfer to larger 
organisms such as mammals can occur via the food chain. Short-term health effects 
on humans can include various cancers, notably leukemia, caused by changes 
in gene regulation, and thyroid disorders. Long-term health effects may include 
heritable genetic mutations transmissible to future generations. This could have 
a potentially negative impact on the human gene pool and human evolution in 
affected areas, especially with the loss of individuals with the least mutations [9]. 
Ultimately, this may affect the fitness of the species and lead to a major decline or 
genetic degradation of select human populations [10].
2. Local health effects
2.1 Epidemiology
The main radioactive contaminants in the immediate vicinity of the Sellafield 
nuclear reprocessing facility have been identified as plutonium [Pu] and americium 
[Am] as a result of soil core samples taken from 95 locations within a few kilometers 
of the Sellafield nuclear complex. High levels of Pu-239 and Pu-240 have been 
deposited within a few hundred meters of the site, declining to lower levels within 
3 km. The activity ratio of these radioisotopes indicates that the plutonium origi-
nated from uranium of low irradiation suggesting that deposition occurred during 
the early years of plant operation. The presence of Am-241 also correlates strongly 
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with the Pu-239 and Pu-240 and is consistent with its derivation from Pu-241 
deposition [11]. Pu-239 is formed by the spontaneous fission of U-238, which is 
a by-product of the uranium enrichment process routinely carried out at nuclear 
power plants [12].
In 1983, a cluster of cancers, most readily produced by ionizing radiation, 
were discovered in Seascale, a village situated 3 km from Sellafield, which is the 
principal nuclear reprocessing plant in the UK. It involved the occurrence of non-
Hodgkin’s lymphoma (NHL) with lymphoblastic leukemia in young people under 
the age of 25, who lived in Seascale in the period between 1955 and 1983 [13]. A 
subsequent scientific study confirmed that there was a marked excess of acute 
lymphatic leukemia (ALL) in Seascale [14]. In 1986, an excess of acute lymphatic 
leukemia was discovered near Dounreay, the site of the only other nuclear repro-
cessing plant in the UK [15]. Finally, in 1993, when an excess of acute lymphatic 
leukemia was also recorded in Egremont, a small town 7 km north of Sellafield, 
the emerging epidemiological pattern could no longer be ignored [14]. In fact, 
the incidence rates of ALL and NHL were increased to a similar extent in Seascale 
when the parents were incomers from other parts of the country or locals sug-
gesting an environmental component to the problem [16]. Moreover, a significant 
excess of these cancers has continued to be observed in Seascale since this data was 
first collected.
Interestingly, one study measured the concentrations of Pu-239 and Pu-240 in 
the teeth of children throughout Great Britain and Ireland. Regression analysis 
showed that the concentrations of plutonium decreased with increasing distance 
from the Sellafield facility and suggests that this plant is not only a source of radio-
active contamination locally, but it may affect a wider population within the British 
Isles [17]. An earlier study noted similar differences for plutonium levels in bone 
collected from people living in West Cumbria as compared with those living at sites 
remote from this location in the UK [18].
Further studies were commissioned by the Irish State to examine the possible 
effects of nuclear pollution from Sellafield on the coast of Ireland. The results 
showed a seacoast effect in coastal areas close to North Wales, particularly in towns 
where there was intertidal sediment contaminated with radioactive material from 
Sellafield or other historical sources. This was evidenced as a sharp rise in risk for 
leukemia in children and adults, especially near the northern entrance of the Menai 
Strait, which has fine intertidal sediment significantly contaminated with pluto-
nium and other radioactive materials from Sellafield [19]. A follow-up localized 
these disturbing results in Caernarfon, Gwynedd, and Anglesey [20]. The explana-
tion given was that sea-to-land transfer of radioactive particles followed by inhala-
tion represented a risk to those living in the 0–1 km coastal strip since the particles 
could be transferred from the lungs to the lymphatic system resulting in leukemia. 
Such observations only serve to highlight the painful fact that acute uncertainties 
exist in the dosimetry of primary alpha-emitters, such as plutonium, in children 
and the fetus [21].
In autopsy tissues from west Cumbrian workers who had been employed in 
the nuclear energy industries, plutonium concentrations have been found to be 
generally higher than tissue concentrations in people from other regions of Great 
Britain. Furthermore, isotopic analysis using mass spectrometry has provided some 
evidence that this plutonium originated from aerial discharges from the British 
Nuclear Fuels Plant at Sellafield [22].
In radiation workers from the Sellafield plant, a significant excess of deaths has 
been recorded from cancer of the pleura and thyroid. In addition, a positive correla-
tion has been observed between accumulated external radiation dose and mortality 
from leukemia, multiple myeloma, and all lymphatic and hematopoietic cancers. 
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There were also significant increases in risk with cumulative plutonium plus 
external radiation doses for all lymphatic and hematopoietic neoplasms. As a result, 
it has been concluded that the cancer incidence in Sellafield employees exposed 
to plutonium was significantly increased as compared with other radiation work-
ers [23]. Furthermore, in a pooled cohort analysis of Sellafield (UK) and Mayak 
(Russia) workers, lung cancer risk from occupational plutonium exposure was 
studied. Poisson regression models provided a clear evidence of a linear association 
between cumulative internal plutonium lung dose and risk of lung cancer incidence 
and mortality in the pooled cohort [24].
2.2 Animal studies
Studies in animals have demonstrated that exposure to relatively large doses 
of plutonium (as compared with human doses) can cause tumors in the tissues in 
which it is retained [25].
As early as 1959, a single inhalation exposure to a smoke of plutonium oxide in 
rats was correlated with characteristic pathologic changes in the lungs at the sites 
where the material was deposited using autoradiographic and histopathologic 
methods. Moreover, the malignant tumors which occurred in many of the animals 
could be related to this severe focal damage in the lungs as a result of the plutonium 
oxide exposure [26]. It has also been recorded that a single intraperitoneal injection 
of monomeric Pu-239 in mice results in a significantly higher incidence of bone 
cancer in females than males, while castration of males equalizes the frequency 
of bone sarcomas in both sexes [27]. In another study, the cancer risk posed by 
Pu-239 was reduced in adult female mice by chelation therapy with subcutane-
ous injections of Zn Na3 diethylenetriaminepentaacetate (Zn-DTPA) [28]. More 
recently, it was demonstrated that catechol-3, 6-bis(methyleiminodiacetic acid) 
(CBMIDA) is as effective as Zn-DTPA and Ca-DTPA in removing plutonium from 
the liver of rats and superior to both Zn-DTPA and Ca-DTPA in removing pluto-
nium from bone [29].
Another significant study with rats found that point mutations in the p53 (or 
Tp53) tumor suppressor gene, which is involved in mediating apoptosis, seem 
to play a role in the development of lung tumors following inhalation exposure 
to plutonium dioxide [30]. However, these base transitions are not associated 
with nuclear accumulation of p53 protein suggesting that this may represent a 
later step in carcinogenesis involving resistance to apoptosis and cell transforma-
tion. Mutations in this gene are often encountered in lung tumors from uranium 
miners, and p53 appears to play a critical role in the cellular response to genetic 
damage caused by radiation in humans [31]. In addition, epigenetic inactivation 
of the p16 gene by methylation is common in rat lung tumors induced by Pu-239. 
The prevalence of p16 methylation in lung adenocarcinoma samples collected 
from Mayak plutonium workers is also significantly increased as compared with 
controls. The p16 protein has been reported to regulate apoptosis in diverse cell 
types [32].
The experimental inhalation of plutonium dioxide aerosols by beagle dogs 
revealed the long-term retention of plutonium in the lungs. Approximately 9% of 
the alveolar plutonium deposits were transferred to hilar lymph nodes by the first 
year and started to be detectable in abdominal lymph nodes about 2 years after 
inhalation [33]. More recent studies provide evidence that lung neoplasms can be 
induced in dogs by Pu-239 and can be associated with the expression of epidermal 
growth factor receptor [EGF-R] as in human lung tumors [34].
Furthermore, beagle dogs exposed to plutonium-nitrate and subjected to its 
retention in their tissues have been diagnosed with tumors in bronchioloalveolar, 
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peripheral, and subpleural alveolar regions of the lung. The TUNEL assay revealed 
an elevation of apoptosis in the tracheal mucosa, tumor cells, and nuclear debris in 
the alveoli and lymph nodes of the beagles with statistically significant modifica-
tions in Fas ligand, B-cell lymphoma 2, and caspase-3 expression. It is of note that a 
comparably exposed human subject in the same study did not develop pulmonary 
tumors or display an elevated rate of apoptosis in lung tissues [35].
2.3 Cell culture studies
Cell studies on peripheral blood lymphocytes from workers with significant 
plutonium body burdens have revealed an increase in chromosome aberrations. 
Radiation-induced breakpoints were randomly distributed among the chromo-
somes according to length. However, the distribution of the breakpoints within the 
chromosomes displayed an excess in the centromeres and telomeres. This study 
suggests that plutonium depositions within the body can cause such aberrations 
since external radiation exposure was taken into account [36]. A further follow-up 
study performed on Sellafield workers with 20–50% and >50% maximum permis-
sible body burdens (MPBB) of plutonium confirmed that these results are consis-
tent with the hypothesis that hematopoietic precursor cells are being irradiated by 
internally deposited plutonium with subsequent selection resulting in only those 
cells with symmetrical aberrations reaching the peripheral lymphocyte pool [37]. 
Presumably, elimination of the nonviable cells occurs via programmed cell death or 
apoptotic pathways.
B lymphocyte precursor cells, which are the target cells for acute lymphoblastic 
leukemia in children, are highly susceptible to the lethal effects of α-particles 
and have a very low probability of surviving a single α-track [38]. Subsequently, 
alpha-irradiation has been reported to cause transmissible chromosomal instabil-
ity, characterized by non-clonal cytogenetic aberrations with a high frequency 
of chromatid-type aberrations and a lower frequency of chromosome-type aber-
rations, in the clonal descendants of human hematopoietic stem cells. Delayed 
apoptotic cell death is evident in these clonal populations [39]. Furthermore, an 
interesting study demonstrated that both high-LET fast neutrons (of the type emit-
ted by plutonium-239) and low-LET 60Co gamma rays induce apoptosis indepen-
dently in resting human peripheral blood lymphocytes. Dose-response curves for 
each of these two types of radiation are characterized by an initial steep increase 
in the number of apoptotic cells below 1 Gy and a flattening of the curves at higher 
doses toward 5 Gy [40].
Apoptosis can also be selectively induced in transformed cells by neighboring 
normal cells via cytokine and reactive oxygen species (ROS)/reactive nitrogen 
species (RNS) signaling. In fact, in rat fibroblasts, high-LET α-particles are more 
effective than low-LET X-rays in stimulating intercellular induction of apoptosis for 
any given irradiated fraction of cells at very low doses. The increase in intercellular 
induction of apoptosis results from nitric oxide free radical (NO*) and peroxidase 
signaling mediated by transforming growth factor beta [TGF-β] [41]. In human 
fibroblasts following exposure to 0.1 and 1 Gy α-particles, irradiated populations 
display a dose-dependent increase in chromosome-type aberrations at the first 
cell division. Nonirradiated neighbor (bystander) fibroblast populations also 
demonstrate elevated chromatid-type aberrations. Both irradiated and bystander 
populations have significantly higher frequencies of chromatid aberrations over 
25 doublings than controls [42]. These results support the increasing evidence that 
the biological effects of ionizing radiation are not limited to irradiated cells, but 
can extend to nonirradiated neighbors and be seen as genomic instability in their 
progeny at subsequent generations.
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In another intriguing study, it was shown that human papillomavirus-
immortalized human bronchial epithelial (BEP2D) cells can undergo malignant 
transformation when exposed to 1.5 Gy of α-particles emitted by a Pu-238 source 
[43]. A non-tumorigenic human thyroid epithelial cell line (HTori-3) has also been 
transformed into tumorigenic cells by exposure to alpha particles in vitro. These 
tumor cells were screened and found to contain experimentally induced mutations 
in the p53 tumor suppressor gene generated by irradiation of the human thyroid 
epithelial cell line [44].
3. Long distance ecosystem effects
3.1 Measurement of plutonium in sea water
Plutonium in the Baltic Sea has been assessed in precipitation, water, sedi-
ments, and microalgae. The major source of plutonium is fallout from nuclear tests, 
while European reprocessing facilities have contributed significant quantities of 
all plutonium isotopes. The Chernobyl accident contributed very little to overall 
plutonium concentrations of Pu-239 and Pu-240, whereas the Pu-238 and Pu-241 
contributions were more significant [45]. Significantly increased concentrations 
of plutonium have also been found in the subsurface layers of the Norwegian and 
Greenland Seas. The plutonium activity ratio [238Pu/239,240Pu] found in both peaks 
displays a significant influence of Sellafield discharges [46]. Measurements of 
isotopic atomic ratios of plutonium in bottom deposit samples from the Norwegian 
and Greenland Seas show that the contribution of α activity of industrial plutonium 
from the European reprocessing plants, mainly Sellafield, on the background of 
global fallouts is 20–50% of total α activity (Pu-238-240) and 70–95% of total β 
activity (Pu-241) [47]. Moreover, a transfer factor for both conservative and non-
conservative (including plutonium) Sellafield discharges has been detected in East 
Greenland Current Polar Water, a water mass which reflects contaminant levels in 
Arctic Ocean surface water [48].
3.2 Measurement of plutonium in plants
An interesting study analyzing Swedish lichen samples from various parts 
of Sweden demonstrated that in the areas most contaminated by the Chernobyl 
accident, the plutonium contributions from Chernobyl were as high as 85%. 
Sellafield-derived neptunium (Np) was found in brown seaweed samples from 
the west coast of Sweden 4–5 years after discharge (1995–1996), suggesting that it 
has greater mobility than plutonium in this particular marine environment [49]. 
Furthermore, the long-lived anthropogenic radionuclides Np-237, Pu-239, and 
Pu-240 were determined in marine environmental samples (seaweed and seawater) 
from Swedish-Danish waters and the North Atlantic Ocean at various locations. 
Most of the Np-237 in these waters is considered to originate from the Sellafield 
plant with some contribution from global fallout. There was quite a wide variation 
in Np-237 activity concentrations in Fucus vesiculosus and Pu-240/Pu-239 atomic 
ratios in F. vesiculosus samples [50]. In Norway, F. vesiculosus samples collected in 
the North Sea, Skagerrak, and in selected fjords also contain Pu-239 and Pu-240 
concentrations with relatively large fluctuations from year to year with a slowly 
decreasing trend in the activity concentrations from 1980 to 2010, possibly coincid-
ing with declining Cap de la Hague emissions. However, seawater samples collected 
in the North Sea near Scotland do not display a similar decreasing trend in Pu-239 
and Pu-240 radioactivity, thereby suggesting a Sellafield effect [51].
Gene Expression and Phenotypic Traits
8
3.3 Measurement of plutonium in marine biota
Plutonium-239 and plutonium-240 concentrations in Baltic biota have 
revealed that these radionuclides are strongly accumulated by some species such 
as algae, benthic animals, and fish [52]. In the southern Baltic Sea, the Pu-239 and 
Pu-240 concentrations in surface seawater samples range from 5.2 mBq m−3 for 
Gdańsk Bay to 150 mBq m−3 for Pomeranian Bay, and plutonium has been found to 
be distributed in parts of cod gills and skin [53]. At the same time, it is important 
to note that the major fraction of plutonium in the Baltic Sea is rapidly associated 
with sediments and only 1% is present in the water column. Therefore, in view 
of the above findings, it is of the utmost importance to identify safe scavenging 
processes and filtration techniques for future remediation efforts [45]. Some of 
the remediation strategies previously adopted for surface waters affected by the 
Chernobyl accident include adding chemicals to bind radionuclides, construc-
tion of traps to contain contaminated sediments, and dredging of contaminated 
deposits [54].
4. Possible mechanisms of alpha- and gamma-radiation carcinogenesis
4.1 An apoptotic model of carcinogenesis
Classically, experimental carcinogenesis is a complex, multistage process includ-
ing initiation, promotion, and malignant progression in which the failure of DNA 
repair mechanisms and the subsequent clonal expansion of damaged cells play a 
pivotal role. However, more recently, it has become apparent that the pathogenesis 
of cancer is closely connected with aberrantly regulated apoptotic cell death and the 
resulting deregulation of cell proliferation [55, 56].
The Ames assay as a universal test for carcinogenicity was based on the classical 
model of carcinogenesis involving the failure of DNA repair mechanisms and the 
subsequent clonal expansion of mutated cells. However, mutagenicity in bacterial 
strains is not always an indicator of carcinogenicity since many carcinogens are not 
mutagenic [57]. Although this may be one feasible mechanism of carcinogenesis in 
laboratory models, it does not adequately fit many existing systems of carcinogen-
esis which are increasingly connected with the dysregulation of apoptotic mecha-
nisms in the cell.
Somatic cell and germline point mutations do occur, and the frequency of muta-
tion can be accelerated by external factors like mutagenic substances such as ion-
izing radiation. Spontaneously, this is still considered to be a relatively slow process 
and, probabilistically, more likely to have an effect on a later step of carcinogenesis 
involving cell immortalization or transformation than to initiate carcinogenesis, 
or, more likely, even to affect future generations. According to Darwinian doctrine, 
random mutations in the general population result in the gradual evolution of a 
species. With exposure to mutagens in the environment, though, this genetic evolu-
tion can be sped up resulting in the acquisition of new traits or characteristics by 
a particular group. Ultimately, there is always the possibility that this unnaturally 
accelerated evolution may negatively impact the fitness of the species.
In the two-stage model of tumor formation (Figure 1), step I exposure to a 
carcinogen, possibly facilitated by a genetic predisposition, results in an epigenetic 
or genetic event causing continuous apoptotic activation of cells in the target tissue. 
In step II, when the carcinogen may or may not be present, resistance to apoptosis 
and continuous cell proliferation result due to another genetic or epigenetic event. 
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The extended proliferation of these somatic cells can result in the development 
of the neoplastic phenotype [58]. According to this model based on human skin 
carcinogenesis, while an epigenetic change is more likely to occur in the first step of 
carcinogenesis, a genetic mutation is more likely to occur in the second step of car-
cinogenesis as a function of probability [59]. A nice example is provided by the p53 
mutations which appear to inhibit cell death in mammalian lung tumors induced by 
plutonium dioxide.
4.2 Alpha- and gamma-radiation-induced apoptosis
It is well known that radioactive metals and their isotopes routinely have long 
half-lives and many emit gamma radiation. As an example, the half-life of ura-
nium-238 [U-238] is 4.46 billion years, while that of U-235 is 704 million years, 
and, although they are primarily alpha-emitters, both also emit gamma radiation. In 
addition, some plutonium radioisotopes with intermediate half-lives (up to thou-
sands of years) emit gamma rays along with alpha and beta particles [60]. Thus, 
the potential health effects on wildlife and humans are virtually unlimited in terms 
Figure 1. 
Two-stage model of tumor formation. Step I exposure to a carcinogen, possibly facilitated by a genetic 
predisposition, results in an epigenetic or genetic event causing continuous apoptotic activation of cells in the 
target tissue. In step II, when the carcinogen may or may not be present, resistance to apoptosis and continuous 
cell proliferation result due to another genetic or epigenetic event.
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of duration once the environment becomes contaminated with significant levels of 
such radioisotopes due to nuclear accidents or nuclear reprocessing activities.
Alpha-irradiation has been reported to cause delayed apoptotic cell death in the 
clonal descendants of human hematopoietic stem cells. Another study has demon-
strated that high-LET fast neutrons (of the type emitted by plutonium-239) induce 
apoptosis in resting human peripheral blood lymphocytes. Apoptosis can also be 
selectively induced in transformed mammalian cells by neighboring normal cells in 
response to high-LET α-particles via cytokine and reactive oxygen species (ROS)/
reactive nitrogen species (RNS) signaling.
Like UV-rays, ϒ-rays are considered to be a complete carcinogen. In one large 
study, 400 days (a little over 1 year) of continuous external ϒ-ray exposure induced 
tumors in a significant percentage of treated mice (>86.7%) and resulted in their 
premature deaths [61]. External exposure to ϒ-rays has been reported to stimulate 
apoptosis in certain cell types including rat thymocytes, mouse myeloid cells, and 
human lymphoid cells. Lymphoblastoid cell lines derived from healthy individu-
als undergo p53-independent apoptosis in response to high-LET radiation and 
p53-dependent apoptosis in response to low-LET radiation [62]. Furthermore, some 
human carcinoma cell lines exposed to internal ϒ-radiation via the decay of a DNA-
incorporated radionuclide [I-125] display radiosensitivity as a result of activation of 
apoptotic pathways [63]. Thus, exposure to both external and internal ϒ-radiation 
sources can stimulate apoptotic cell death.
4.3 Uranium and apoptotic pathways
It appears that different isotopic compositions of uranium like many other 
heavy metals can penetrate to the subcellular level resulting in bioaccumulation and 
initiation of oxidative stress in zebrafish tissues [64]. At subtoxic concentrations 
(>100 μM), depleted uranium precipitates mainly in the nucleus of the human 
kidney, liver, and neuronal cell lines [65]. Chemically, uranium can activate oxygen 
species in the course of redox reactions via the redox chemistry of transition metals 
[66] and enhance free radical production via the ionization phenomenon induced 
by alpha particle emissions to produce DNA damage in the form of double-strand 
breaks [67, 68]. Although uranium can emit alpha, beta, and gamma radiation, 
alpha particle emissions are of the greatest relevance in relation to depleted ura-
nium, which is a waste product of uranium enrichment [69]. Thus, uranium is 
capable of initiating chemotoxicity and radiotoxicity [70] via the generation of free 
oxygen species and possibly via more direct mechanisms involving DNA damage in 
cells. Both biochemical pathways can stimulate cell death or apoptosis, which has 
been linked to carcinogenesis in various cancer models. In fact, the loss of equilib-
rium between cell death and cell proliferation in a tissue may play a critical role in 
tumor formation (Figure 1) [71, 72].
4.4 Plutonium and apoptotic pathways
Plutonium is mainly deposited in the human lungs, liver, and skeleton, where 
it is retained for many years. Pu-239 has a physical half-life of 24, 110 years and a 
biological half-life of 20–50 years [73]. Intravascular administration of plutonium 
citrate in the human body results in radioactive concentration in the bone mar-
row, the liver, the bone, the spleen, the kidney, and the lungs [74]. Environmental 
transfer is determined by its solubility in human body fluids such as its measure-
ment via urine bioassays [25]. This environmental plutonium transfer can give 
rise to α-particle radiation doses of ≈3–7 μSv/a in human bone and ≈10–20 μSv/a 
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in the liver [12], which may result in chemo- and radiotoxicity via the ionization 
phenomenon induced by alpha particle emissions similar to that caused by depleted 
uranium. Previously, the incidence of multiple primary cancers in Nagasaki plu-
tonium atomic bomb survivors has been associated with radiation exposure [75]. 
Interestingly, recent autoradiographic analysis of paraffin-embedded tissue samples 
from Nagasaki atomic bomb victims (who died within 5 months after the bomb-
ing) has confirmed the presence of alpha-tracks from deposited plutonium, and, 
so, the contribution of internal plutonium radiation exposure [Pu-239] to overall 
toxicity cannot be dismissed [76]. Thus, a two-stage model of tumor formation in 
the case of plutonium is plausible, possibly with a degree of apoptosis occurring 
in the transformed cell population due to continued exposure to the internalized 
plutonium (Figure 2).
Figure 2. 
Two-stage model of tumor formation for plutonium. A two-stage model of tumor formation in the case of 
plutonium is plausible, possibly with a degree of apoptosis occurring in the transformed cell population due to 
continued exposure to the internalized plutonium.
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5. Discussion
Epidemiological studies in the north of England revealed a cluster of cancers 
most readily produced by ionizing radiation in three villages situated close to 
nuclear reprocessing plants. When an elevated incidence of acute lymphatic 
leukemia was observed in children living in all three locations, the emerging pattern 
could no longer be ignored. Subsequently, the deposition of radioactive plutonium 
was found in the immediate vicinity of the Sellafield plant, and locally caught fish 
and shellfish were found to be contaminated with toxic radionuclides, particularly, 
plutonium. A study that measured the concentration of plutonium in the teeth of 
children in Great Britain and Ireland concluded that it decreased with increasing 
distance from the Sellafield facility and suggested that this plant was not only a 
source of radioactive contamination locally, but that it may be affecting a wider 
population within the British Isles. Further studies commissioned by the Irish 
State found a sharp rise in the risk for leukemia in children and adults, especially 
near the northern entrance of the Menai Strait, which has fine intertidal sedi-
ment significantly contaminated with plutonium and other radioactive materials 
from Sellafield due to the sea-to-land transfer of radioactive particles. Plutonium 
concentrations in west Cumbrian workers from the nuclear energy industries were 
generally higher at autopsy than tissue concentrations in people from other regions 
of Great Britain, and isotopic analysis confirmed that this plutonium originated 
from aerial discharges from the British Nuclear Fuels Plant at Sellafield. In fact, the 
cancer incidence in Sellafield employees exposed to plutonium was significantly 
increased as compared with other radiation workers. A positive correlation was 
observed between accumulated external radiation dose and mortality from leuke-
mia, multiple myeloma, and all lymphatic and hematopoietic cancers. There were 
also significant increases in risk with cumulative plutonium plus external radiation 
doses for all lymphatic and hematopoietic neoplasms. Moreover, a combined study 
between Sellafield and Mayak nuclear reprocessing plants found evidence of a 
linear association between cumulative internal plutonium lung dose and risk of 
lung cancer incidence.
Animal studies in rats revealed that a single inhalation of plutonium oxide 
smoke can result in malignant tumors of the lungs. A single intraperitoneal injec-
tion of plutonium-239 in mice particularly predisposes females to bone cancer. 
Plutonium dioxide inhalation in rats is associated with lung tumors displaying point 
mutations in the p53 tumor suppressor gene. Mutations in p53 are found in lung 
tumors from uranium miners, as well, suggesting a similar mechanism of carcino-
genesis. Inactivation of the p16 gene by methylation is common in rat lung tumors 
induced by Pu-239. Methylation of p16 is also observed in lung adenocarcinomas 
from Mayak plutonium workers. Lung neoplasms can be induced in beagle dogs 
by Pu-239 and can be associated with the expression of epidermal growth factor 
receptor [EGF-R] as in human lung tumors. Furthermore, beagle dogs exposed to 
plutonium-nitrate have been diagnosed with tumors in bronchioloalveolar, periph-
eral, and subpleural alveolar regions of the lung.
Chromosome studies with peripheral blood lymphocytes from plutonium 
workers may provide indirect evidence that hematopoietic precursor cells are 
being irradiated by internally deposited plutonium with subsequent selection and 
elimination of badly damaged cells via apoptosis. B lymphocyte precursor cells are 
highly susceptible to the lethal effects of α-particles, and high-LET fast neutrons (of 
the type emitted by plutonium-239) induce apoptosis in resting human peripheral 
blood lymphocytes. Delayed apoptotic cell death is evident in clonal descendants of 
human hematopoietic stem cells exposed to alpha-irradiation. Apoptosis can also be 
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selectively induced in transformed rat fibroblasts by neighboring normal cells via 
cytokine and reactive oxygen species (ROS)/reactive nitrogen species (RNS) signal-
ing. It has been shown that human papillomavirus-immortalized human bronchial 
epithelial (BEP2D) cells can undergo malignant transformation when exposed to 
1.5 Gy of α-particles emitted by a Pu-238 source.
6. Conclusions
Thus, according to a new method for cancer risk assessment based on an apop-
totic model of carcinogenesis, there is sufficient evidence to support that plutonium 
is a carcinogen associated with the etiology of leukemia and lung cancer in humans, 
especially when it is internalized from the environment. Comparative apoptosis 
studies in normal bronchial epithelial cells exposed independently to α-particles 
from a Pu-239 source and plutonium citrate might be useful in exploring the differ-
ing effects of external and internal alpha-irradiation.
In addition, recent results from many laboratories show that chromosomal 
instability in proliferating mammalian cells is characterized by a persistent increase 
of chromosomal aberrations and rearrangements occurring de novo during succes-
sive cell generations. This phenotype can be induced equally by low- and high-LET 
irradiation in lymphocytes at very low doses of exposure, conceivably contributing 
to cancer risk [42, 77]. The potential future implications in select human groups 
living in environments contaminated with radioactive substances are staggering 
and may include ailing populations with the elimination of fit individuals from the 
gene pool due to persistent illness or disease.
Moreover, the possibility of detecting the biological effects of Sellafield radioac-
tive contamination as far afield as Scandinavia is a distinct reality since significant 
quantities of radionuclides can become airborne in seaspray and be transported 
inland by the wind for long distances. Plutonium from the Sellafield plant has 
been identified in coastal areas of North Wales where it has been correlated with 
an increased risk for leukemia. It has also been detected in the Baltic Sea, the 
Norwegian and Greenland Seas, and in seawater and seaweed collected from 
Swedish-Danish waters. Furthermore, plutonium-239 and plutonium-240 have 
been found in the gills and skin of cod from the Baltic Sea. Therefore, combined 
radiation risks including a Sellafield contribution may be elevating cancer rates in 
Scandinavian populations.
In this day and age of increasingly widespread radioactive pollution, heavy 
metal chelation therapy is an essential addition to all modern hospitals. As an 
example, injections of a chelation agent, Zn-DTPA, have been found to be useful 
for plutonium detoxification and reducing the plutonium-associated cancer risk in 
female mice. Although the biochemical pathways for plutonium detoxification in 
the human body are not well understood, free radicals are eliminated via various 
antioxidant activities including enzymes such as superoxide dismutase, catalase, 
glutathione peroxidase, and glutathione S-transferase. Zinc supplementation has 
also been reported to be potentially beneficial in ameliorating the health hazards of 
nuclear waste such as depleted uranium, which may generate free radicals as a result 
of similar cellular mechanisms to plutonium. Thus, zinc absorption via the regular 
use of zinc oxide-based sunscreens may provide some protection against certain 
heavy metal environmental pollutants [78, 79].
Finally, this grave environmental issue begs the question of moral culpability 
and social responsibility. Therefore, it is suggested that radionuclide remediation 
[79] should be practiced and promoted by violators of international nuclear safety 
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regulations, Sellafield in this particular case. Compensation should be meted out to 
the injured parties in the case of nuclear accidents at Sellafield and Cap de la Hague. 
Finally, the frequency of accidents and future costs of such negligence at nuclear 
and reprocessing installations including the possible decimation of the species 
should be weighed carefully by countries when considering the attractive attributes 
of alternative clean energy sources like wind, water, and solar power. Once nuclear 
power plants start springing up around the world and producing vast quantities of 
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